{
  "ef_id": "c3d88718-a1a1-43af-8886-a1b4c89c188f",
  "enrichment_payload": {
    "canonical_actors": [
      {
        "name": "Merck",
        "role": "initiator"
      },
      {
        "name": "UK",
        "role": "target"
      }
    ],
    "policy_status": null,
    "time_span": {
      "start": "2025-09-11",
      "end": null
    },
    "magnitude": [],
    "official_sources": [],
    "why_strategic": "Major pharma investment withdrawal signals UK's declining competitiveness in life sciences sector, potentially impacting biosecurity and medical innov"
  },
  "enriched_at": "2025-09-19 20:47:15.274630",
  "enrichment_version": "v1.0",
  "sources_found": 0,
  "tokens_used": 0,
  "processing_time_ms": 7721,
  "status": "completed",
  "error_message": null
}